If you have news tips, please send them to [email protected]
Mike Haney: So we're going to talk a lot today about GLP-1s, but I want to start by talking about obesity in general because I want to sort of frame this conversation you know, in this modern age of people being able to go online and get a GLP-1 prescription in 10 minutes, or micro-dosing it, or taking it for all sorts of different clinical implications
In multiple case reports, hydroxychloroquine administration for the treatment of COVID-19 in G6PD-deficient patients revealed a dramatic drop in hemoglobin and haptoglobin, indicating erythrocyte breakdown [56,57,58,59,60]
Brennan, R., Wells, J
The primary objective of this analysis was to compare the time until the first occurrence of confirmed major adverse cardiovascular events with four components (MACE-4: cardiovascular death, myocardial infarction, stroke, and hospitalized unstable angina) between the combined tirzepatide groups and the control groups